Differential mucin phenotypes and their significance in a variation of colorectal carcinoma

Figure 4 Survival curves. A-D: Well-to-moderately differentiated adenocarcinoma (WMDA); E-H: Poorly differentiated adenocarcinoma (PDA); I and J: Mucinous adenocarcinoma (MUA). A: Recurrence/metastasis-free; B: Overall survival curves with or without mucin (MUC) 2 expression of WMDA; C: Recurrence/metastasis-free; D: Overall survival curves with or without MUC5AC expression; E: Recurrence/metastasis-free; F: Overall survival curves with or without MUC2 expression; G: Recurrence/metastasis-free; H: Overall survival curves with or without MUC5AC expression; I: Recurrence/metastasis-free; J: Overall survival curves with or without MUC5AC expression. Curves were generated using the Kaplan-Meier method and compared by log-rank tests. P values were derived from comparing mucin-negative and -positive tumors.